Exhale

The official blog of the Lung Institute.

How Cellular Treatment Helped One COPD Patient Regain Her Life

1 May 2018
| Under COPD, Patient Stories, Uncategorized | Posted by | 0 Comments

Chronic obstructive pulmonary disease (COPD), a chronic lung disease characterized by shortness of breath, wheezing, chest tightness and constant coughing, can feel like a death sentence to many. For those diagnosed with a chronic lung disease, the gradual loss of abilities and the progression of the disease can be devastating. But for patients like Vaneta H., alternative treatments like cellular therapy can help improve their lung function by promoting the growth of healthy pulmonary tissue.

Vaneta’s life with severe COPD

Vaneta’s doctor diagnosed her with severe COPD seven years ago. When she asked what to do, he told her, “You go home and wait to die.”

As her disease progressed, Vaneta found herself wheelchair bound and bedridden. It became difficult to walk the 30 feet from her bedroom to her bathroom, and she often ended up so out of breath from the short trip that she wondered if she could even make it back. Over time, her skin lost its color. She couldn’t visit the grocery store for three years. She admits that there were times she and her family members weren’t sure how much longer she would survive.

How cellular treatment helped Vaneta breathe easier

Vaneta first heard about cellular treatment after her brother had stem cell therapy for his back. He wondered out loud if there might have something similar for her chronic lung condition. For two years, Vaneta looked at the Lung Health Institute’s website – until she finally decided to seek her first treatment in 2017.

Now, those previously impossible grocery store trips have become part of her regular routine again. She’s been able to temporarily remove the oxygen tubes that she once used 24/7 and has stopped using the tank at night. Then came the time she was shopping with her grandson and noticed her portable tank had run out of oxygen – and she didn’t even feel winded.

“I used to panic if the electricity went out, like, ‘We need to go to a hotel now!’ ” she recalls. “Whereas now, if I don’t have oxygen for a while, I don’t feel like I’m going to die.”

The color returned to her face, and she says that even her hearing improved. She no longer uses her rescue inhaler and has been able to cut back on the medication she used to take daily.

Vaneta describes her experience with the Lung Institute as surprisingly pleasant. She feels like she’s received special attention, and she describes the medical facilities as more comfortable than your typical treatment center.

While there is no cure for COPD, Vaneta is one of many patients who have experienced benefits from cellular treatment. For more information on the Lung Health Institute’s therapy programs, contact a patient coordinator today at (800) 729-3065.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.